Mental health courts in the US, which serve fewer than 1% of over 2 million people with serious mental illness entering jail each year, are failing to live up to their promise due to high operating costs and low resources, according to advocates, attorneys, clinicians, and researchers. Critics argue the courts focus on strict requirements like regular hearings and drug screenings rather than treatment and there’s no conclusive evidence they improve long-term outcomes for participants or stop them re-entering the justice system.
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario
Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial endpoint data. Analysts see Clario’s offerings as highly complementary
